Dr. Paula Raffin Pohlmann, MD, PhD, MSC

Dr. Paula Raffin Pohlmann, MD, PhD, MSC

Dr. Paula Raffin Pohlmann, MD, PhD, MSC

Languages: English, Portuguese
Fax: (202) 444-7009

Contact this Provider:

Specialties
  • Medical Oncology
Conditions I Treat
  • abdominal cancer
  • cancer
  • cancer during pregnancy
  • cancer genomics
  • cancer pain
  • Show All
Procedures I Perform
  • adjuvant chemotherapy
  • biological targeted therapy
  • cancer chemotherapy
  • chemoradiation
  • early detection of cancer
About the Provider

Paula R. Pohlmann, MD, PhD, is a board-certified medical oncologist with more than 20 years of experience in cancer treatment and research. In her clinic at the Lombardi Comprehensive Cancer Center, Dr. Pohlmann treats patients with breast cancer, and also conducts phase I, II and III clinical trials involving any malignancy, in particular breast, gastrointestinal and gynecologic.
The recipient of many grants focused on breast cancer, gynecological cancer, molecular targets and immunotherapy, Dr. Pohlmann has published extensively. She currently leads several clinical trials developing new diagnostic biomarkers and therapies.
Dr. Pohlmann's Philosophy of Care
I work methodically to provide each patient with exceptional cancer care and treatment. To start, I review all previous treatment with my patients. I seek to understand my patients' expectations and wishes and then discuss available therapies with them, including innovative treatments and alternatives. These discussions help me develop a personalized treatment plan based on cutting edge scientific evidence that may offer solutions for each patient's condition.
My work aims to return every person with cancer back to a normal, healthy life quickly, by providing the most advanced, professional, sensitive and compassionate patient care available.

Education
  • Residency Program: Vanderbilt University Medical Center (2011)
  • Fellowship Program: Vanderbilt University (2009)
  • Fellowship Program: Vanderbilt University Medical Center (2009)
  • Fellowship Program: Hospital de Clinicas (1997)
  • Residency Program: Hospital de Clinicas (1994)
  • Medical School: Universidade Federal do Rio Grande do Sul (1992)
  • Board Certification: American Board of Internal Medicine, Internal Medicine
  • Board Certification: American Board of Internal Medicine, Medical Oncology
Publications
i. Original Papers in Refereed Journals
  • Lynce F, Blackburn MJ, Cai L, Wang H, Rubinstein L, Harris P, Isaacs C, Pohlmann PR. Characteristics and outcomes of Breast Cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. Breast Cancer Res Treat. 2017 Nov 8. doi: 10.1007/s10549-017-4563-3. [Epub ahead of print]. PMID: 29119354 [link]
  • Mahajan AS, Sugita BM, Duttargi AN, Saenz F, Krawczyk E, McCutcheon JN, Fonseca AS, Kallakury B, Pohlmann P, Gusev Y, Cavalli LR. Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors. PLoS One. 2017 Oct 19;12(10):e0186190. doi: 10.1371/journal.pone.0186190. eCollection 2017. PMID: 29049316 [link]
  • Robinson BN, Newmana AF, Tefera E, Herbolsheimer P, Nunes R, Gallagher C, Randolph-Jackson P, Omogbehin A, Dilawari A, Pohlmann PR, Mohebtash M, Lee Y, Ottaviano Y, Mohapatra A, Lynce F, Mete M, Swain SM. Video Intervention Increases Participation of Black Breast Cancer Patients in Therapeutic Trials: INSPIRE. NPJ Breast Cancer. 2017 Sep 18;3:36. doi: 10.1038/s41523-017-0039-1. eCollection 2017. PMID: 28944289 [link]
  • Jansen VM, Bhola N, Bauer JA, Formisano L, Lee KM, Hutchinson K, Sanders M, Sanchez V, Pohlmann PR, Pishvaian M, Dugger TC, Knudsen E, Witkiewicz A, Wei W, Estrada V, Moore P, Arteaga CL. Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer. Cancer Res. 2017 May 1;77(9):2488-2499. doi: 10.1158/0008-5472. CAN-16-2653. Epub 2017 Mar 1. PMID: 28249908 [link].
  • Yan HP, Roberts LJ, Davies SS, Pohlmann P, Parl FF, Estes S, Maeng J, Parker B, Mernaugh R. Isolevuglandins as a gauge of lipid peroxidation in human tumors. Free Radic Biol Med. 2017 May;106:62-68. doi: 10.1016/j.freeradbiomed.2017.02.020. PMID: 28189846 [link]
  • Gao JJ, Tan M, Pohlmann PR, Swain SM. HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. Clin Breast Cancer. 2016 Aug 27. pii: S1526-8209(16)30235-X. doi: 10.1016/j.clbc.2016.08.005. [Epub ahead of print] PMID: 27692565. [link]
  • Madhavan S, Aisner DL, Sheahan L, Sood N, Reddy S, Picora A, Wilhelm E, Volk J, Cusano D, Lucia K, Pohlmann PR, Marshall JL. Barriers to Implementation of Precision Medicine for Cancer Treatment in the U.S. Healthcare System. The Journal of Precision Medicine. 2016:48-56. [link]
  • Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY2 Investigators. Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749. PubMed PMID: 27406347. [link]
  • Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY2 Investigators. Adaptive Randomization of Neratinib in Early Breast Cancer. N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750. PubMed PMID: 27406346. [link]
  • Shah AT, Demory Beckler M, Walsh AJ, Jones WP, Pohlmann PR, Skala MC. Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma. PLoS One 2014 Mar 4;9(3):e90746. doi: 10.1371/journal.pone.0090746. eCollection 2014. PubMed PMID: 24595244; PubMed Central PMCID: PMC3942493. [link]
  • Chung CH*, Pohlmann PR*, Rothenberg ML, Burkey BB, Parker J, Palka K, Aulino J, Puzanov I, Murphy B. Insulin-like growth factor-I receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma. Head & Neck. 2011 Dec; 33(12):1804-8 (Epub 2010 Jul 22). PMID: 20652976 [link] *co-first authors
  • Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough WG, Wheeler D, Harari P, Guo Y, Shyr Y, Slebos RJ, Chung CH. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PLoS One. 2010 Sep 13;5(9):e12702. PMID: 20856931 [link]
  • Savani B, Pohlmann P, Jagasia M, Chinratanalab W, Kassim A, Engelhardt B, Greer J, Schuening F, Goodman S. Does peri-transplant use of rituximab reduce the risk of EBV-reactivation and PTLPD? Blood. 2009 Jun 11;113(24):6263-4. PMID: 19520823 [link]
  • Pohlmann PR, Mernaugh R, Goff LW. Chemotherapy and immunotherapy in metastatic colorectal cancer. N Engl J Med. 2009 May 14;360(20): 2134; author reply 2135-6. PMID: 19439750 [link]
  • Caleffi M, Ribeiro R, Duarte D, Ashton-Prolla P, Bedin A, Skonieski G, Zignani J, Giacomazzi J, Franco L, Graudenz M, Pohlmann P, Fernandes J, Kivitz P, Weber B. A model to optimize public health care and downstage breast cancer in limited-resource populations in Southern Brazil (Porto Alegre Breast Health Intervention Cohort). BMC Public Health. 2009 Mar 13;9:83. PMID: 19284670 [link]
  • Menke CH, Pohlmann PR, Backes A, Cericatto R, Oliveira M, Bittelbrunn A, Schwartsmann G. Tumor size as a surrogate end point for the detection of early breast cancer: a 30-year (1972-2002), single-center experience in southern Brazil. Breast J. 2007 Sep-Oct;13(5):448-56. PMID: 17760665 [link]
  • Schwartsmann G, DiLeone LP, Horowitz M, Schunemann D, Cancella A, Pereira AS, Richter M, Souza F, da Rocha AB, Souza FH, Pohlmann P, De Nucci G. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs. 2006 Sep;24(5):403-12. PMID: 16505950 [link]
  • Toebak MJ*, Pohlmann PR*, Sampat-Sardjoepersad SC, von Blomberg BM, Bruynzeel DP, Scheper RJ, Rustemeyer T, Gibbs S. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol in Vitro. 2006 Feb;20(1):117-24. PMID: 16099135 [link] *co-first authors
  • Middelburg R, de Haas RR, Dekker H, Kerkhoven RM, Pohlmann PR, Fuentes-Alburo A, Mohar A, Pinedo HM, Lankelma J. Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer. Clin Cancer Res. 2005 Mar 1;11(5):1863-9. PMID: 15756011 [link]
  • Pinedo HM, Buter J, Luykx-de Baker SA, Pohlmann PR, van Hensbergen Y, Heideman DAM, van Diest PJ, de Gruijl TD, van der Wall E. Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumor-draining lymph node dendritic cells. Eur J Cancer. 2003 May;39(8):1061-7. PMID: 12736104 [link]
  • Pohlmann P, DiLeone LP, Cancella AI, Caldas AP, Dal Lago L, Campos O Jr, Monego E, Rivoire W, Schwartsmann G. Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix. Am J Clin Oncol. 2002 Oct;25(5):496-501. PMID: 12393992 [link]
  • Schwartsmann G, Mans DR, Menke CH, Xavier N, Caleffi M, Ferreira Filho AF, Schunemann H, Kalakun L, Koya R, Pohlmann P, Venegas LF. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer. Oncology (Huntingt). 1997;11(4 Suppl 3):24-9. PMID: 9144687 [link]
  • Daudt AW, Prolla JC, Dietz J, Grassi PR, Arnt CA, Loss JF, Costa LA, Pohlmann PR. Tobacco-related diseases: a 21-year study (1970-1990) of the mortality rate in the state of Rio Grande do Sul, Brazil. The Journal of Smoking-Related Disorders. 1993;4(3):155-163. ISSN: 09592431 [link]
  • Dietz J, Prolla JC, Pohlmann PR, Loss JF, da Costa LA, Daudt AW, Grassi P, Achutti AC. Mortality from uterine cervix cancer in Rio Grande do Sul. Rev Assoc Med Bras. 1993 Jul-Sep;39(3):146-50. (Portuguese) PMID: 8281197 [link]
  • Loss JF, Barrionuevo AA, Pohlmann PR. Estudantes de Medicina: II. Informações e medo da SIDA. Revista de Medicina ATM. 1992;13:65-9. (Portuguese)
  • Barrionuevo AA, Pohlmann PR, Loss JF. Estudantes de Medicina: I. Aprendizado dos procedimentos básicos fundamentais à medicina. Revista de Medicina ATM. 1992;13:59-64. (Portuguese)
  • Pohlmann PR, Loss JF, Marzola B, Polanczyk CA, Zampese MS, Kronfeld M. Sarcoma de Kaposi e SIDA - HCPA: avaliação da sobrevida. Revista de Medicina ATM. 1992;13:76-80. (Portuguese)
  • Loss JF, Pohlmann PR. Aspectos Emocionais da Síndrome da Imunodeficiência Adquirida em Pediatria. Revista de Medicina ATM. 1992;13:164-8. (Portuguese)
  • Pohlmann PR, Loss JF, Barrionuevo AA. Estudantes de Medicina: III. O que sabem sobre a organização do sistema de saúde? Revista de Medicina ATM. 1992;13:70-5. (Portuguese)
  • Pohlmann PR, Loss JF, Flores C, Bolzzoni A, Duncan BB, Zimmer PM. Smoking in Porto Alegre: prevalence and the role of health professionals in its prevention. AMB Rev Assoc Med Bras. 1991 Jan-Mar;37(1):8-14. (Portuguese) PMID: 1658870 [link]
ii. Reviews or Editorials in Refereed Journals
  • Pohlmann PR and Isaacs C. Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few. J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx142. PMID: 28922782 [link]
  • Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev. 2016 Nov 22; 11:CD005342. Review. PMID: 27873308 [link]
  • Rosa DD, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev. 2012 Jun 13; 6:CD005342. PMID:22696349 (Review) [link]
  • Rosa DD, Medeiros LR, Edelweiss MI, Bozzetti MC, Pohlmann PR, Stein, AT, Dickinson HO. Adjuvant chemotherapy for early stage cervix cancer. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005342. PMID: 19588370 (Review) [link]
  • Pohlmann PR, Mayer IA, Mernaugh R. Resistance to trastuzumab in breast cancer. Clin Cancer Res. 2009;15(24):7479-91. NIHMSID 406899 PMID: 20008848 (Review) [link]
  • Medeiros LR, Rosa DD, Edelweiss MI, Stein AT, Bozzetti MC, Zelmanovicz A, Pohlmann PR, Meurer L, Carballo MT. Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):192-202. (Review) PMID: 15823099 [link]
  • Rosa DD, Medeiros LR, Bozzetti MC, Edelweiss MI, Pohlmann PR, Stein, AT. Adjuvant chemotherapy for early stage cervix cancer (Protocol). The Cochrane Database of Systematic Reviews. 2005;3:1-8. (Review)
  • Medeiros LR, Rosa DD, Bozzetti MC, Edelweiss MI, Stein AT, Pohlmann PR, Zelmanowicz AM, Ethur AB, Zanini RR. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer (Protocol). The Cochrane Database of Systematic Reviews. 2005;3:1-12. (Review)
  • Pohlmann PR, Suchil Bernal L, Fuentes Alburo A, Buter J, Gallardo Rincon D, Mohar A, Mayordomo JI, van der Hoeven JJM, van der Wall E, de Gruijl T, Pinedo HM. Prolonged neoadjuvant treatment plus GM-CSF in locally advanced breast cancer: Clinical and biological concepts. Rev Oncol (Clinical and Translational Oncology). 2004;6(3):130-9. (Review) [link]
  • Venegas LF, Pohlmann PR, Balbinot AL, Schuck E, Oliveira CTM, Frank KJ, Dillemburg CF, da Costa MS, Rivero LF, Putten ACK. Primary splenic angiosarcoma: case report and literature review. Rev Bras Cancerol. 1998; 44 (1):51-6. (Review) [link]
iii. Books or Chapters in Books (indicate if refereed)
  • Lynce F and Pohlmann PR. Premalignant Breast Conditions and in Situ Disease, Part 3 Solid Malignancies, Chapter 13 Breast Cancer. In: Isaacs C. Hoffman and Abeloff’s Hematology Oncology Review. Elsevier Inc. 2018. Page 90-97.
  • Pohlmann PR and Tan A. Metastatic Breast Cancer, Part 3 Solid Malignancies, Chapter 13 Breast Cancer. In: Isaacs C. Hoffman and Abeloff’s Hematology Oncology Review. Elsevier Inc. 2018. Page 77-89.
  • Watson G, Goff L, Shi C, Pohlmann PR. HER2 (ERBB2) in Gastric Cancer. My Cancer Genome http://www.mycancergenome.org/content/disease/gastric-cancer/erbb2/ (Updated June 18). 2015.
  • Schwartsmann G, Cornelio D, Pohlmann PR. Oncology Section [Modulo Oncologia]. In: Lopes AC. Tratado de Clinica Medica. 3rd Edition. Sao Paulo: Editora Roca. 2014
  • Schwartsmann G, Cornelio D, Pohlmann PR. The Basis for Chemotherapy [Bases da Quimioterapia]. In: Lopes AC and Amato Neto V. Tratado de Clinica Medica. 2nd Edition. Sao Paulo: Editora Roca. 2007.
  • Zimmer A, Pohlmann PR. Humoral Immunity [Imunidade Humoral]. In: Scroferneker ML, Fisher G. Imunologia Básica e Aplicada. 2nd Edition. Sao Paulo: Segmento Farma. 2007.
  • Girardi F, Pohlmann PR. Cellular Immunity [Imunidade Celular]. In: Scroferneker ML, Fisher G. Imunologia Básica e Aplicada. 2nd Edition. Sao Paulo: Segmento Farma. 2007.
  • Girardi F, Pohlmann PR. Tumor Immunology [Imunologia Tumoral]. In: Scroferneker ML, Fisher G. Imunologia Básica e Aplicada. 2nd Edition. Sao Paulo: Segmento Farma. 2007.
  • Pohlmann PR. Breast Cancer Molecular Biology [Biologia Molecular do Câncer de Mama]. In: Duarte DL, A Mama em Imagens. Editora Guanabara Koogan S/A. 2006.
  • Pohlmann PR, Schwartsmann G. New Combined Therapies [Novas Combinações Terapêuticas] – Chapter 36. In: Ferreira CG, Rocha JC. Oncologia Molecular. 1st Edition. São Paulo: Editora Atheneu. 2004.
  • Pohlmann PR. Chemoprevention [Químio-Prevenção] – Chapter 20. In: Cancerologia para Leigo. 1st Edition. Porto Alegre: Editora Conceito. 2001.
  • Scroferneker ML, Pohlmann PR, Editors. Basic and Applied Immunology [Imunologia Básica e Aplicada]. 578p. Porto Alegre: Sagra Luzzatto. 1998.
  • Eckert GU, Barrionuevo AA, Pohlmann PR. Lymphatic Organs [Órgãos Linfóides] - Chapter 1. In: Scroferneker ML, Pohlmann PR. Imunologia Básica e Aplicada. 1st Ed. Porto Alegre: Sagra Luzzatto. 1998.
  • Pohlmann PR. The Cells of Immune System [Células do Sistema Imune] - Chapter 2. In: Scroferneker ML, Pohlmann PR. Imunologia Básica e Aplicada. 1st Edition. Porto Alegre: Sagra Luzzatto. 1998.
  • Furian TQ, Pohlmann PR. Tumor Immunology [Imunologia dos Tumors]- Chapter 28. In: Scroferneker ML, Pohlmann PR. Imunologia Básica e Aplicada. 1st Edition. Porto Alegre: Sagra Luzzatto. 1998.
  • Practice Guidelines on the Treatment of Patients with Cancer of the University Hospital [Rotinas Assistenciais para o Atendimento de Pacientes com Câncer no Hospital de Clínicas de Porto Alegre]. School of Medicine – Universidade Federal do Rio Grande do Sul. 1997.
  • Pohlmann PR. Tumor Immunology [Imunologia dos Tumores]- Chapter 28. In: Scroferneker ML. Notas de Imunologia. Porto Alegre: Editora da Universidade (Universidade Federal do Rio Grande do Sul). 1996.
  • Crestani J, Pohlmann PR, Scroferneker ML. Type I Hypersensitivity reactions [Hipersensibilidade tipo I] - Chapter 15. In: Scroferneker ML. Notas de Imunologia. Porto Alegre: Editora da Universidade (UFRGS). 1996.
  • Pohlmann PR. The Cells of Immune System [Células do Sistema Imune] - Chapter 2. In: Scroferneker ML. Notas de Imunologia. Porto Alegre: Editora da Universidade (UFRGS). 1996.
  • Pohlmann PR. Lymphatic Organs [Órgãos Linfóides] - Chapter 1. In: Scroferneker ML. Notas de Imunologia. Porto Alegre: Editora da Universidade (Universidade Federal do Rio Grande do Sul). 1996.
  • Pohlmann PR, Venegas LF, Ferreira Filho AF, Machado VL, Fleck J. Suspeita de Neoplasia - Chapter 81. In: Souza CEL, Deboni BA, Mroninski CRL, Figueira CF, Vettorazzi J, Spagnol Jr SA. Medicina Interna: Do Diagnóstico ao Tratamento. Porto Alegre: Artes Médicas. 1995
  • Venegas LF, Pohlmann PR, Machado VL. Renal Cell carcinoma [Carcinoma de Células Renais] - Chapter 9. In: Souza CEL, Deboni BA, Mroninski CRL, Figueira CF, Vettorazzi J, Spagnol Jr SA. Medicina Interna: Do Diagnóstico ao Tratamento. Porto Alegre: Artes Médicas. 1995.
  • Pohlmann PR, Ferreira Filho AF, Schwartsmann G. Breast Cancer Chemotherapy [Quimioterapia do Câncer de Mama] - Chapter 21. In: Dias EN, Caleffi M, Salvador Silva HM, Figueira Filho ASS. Mastologia Atual, Livraria e Editora Revinter Ltda. 1994.
Publications/Presentations

  • Podium and poster presentation: Tumor profiling of 1168 geriatric breast tumors, ASCO Breast Symposium, September 2015. San Francisco, California.
  • Principal Investigator, Novel Diagnostic to Predict Patient Responsiveness to Trastuzumab for testing of NSABP B-41 clinical trial samples. October 2015. Washington, DC.
  • Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC). Abstract Temporary ID#169304. 2016 ASCO Annual Meeting. Chicago, Illinois.
  • Co-editor, "Frontiers in Women's Cancers" section, Frontiers in Oncology, Lausanne Switzerland.
  • A phase I, dose-escalation, multicenter study of ACT-PFK-158, 2HCl in patients with advanced solid malignancies explores a first-in-human inhibitor of glycolysis. J Clin Oncol 33, 2015 (suppl 3; abstr TPS494). 2015 Gastrointestinal Cancers Symposium, San Francisco, California (abstract).

Insurance


Practice Locations
Member of Medical Staff
  • MedStar Georgetown University Hospital
Awards
  • Career Development Award. Kalf Research Fellowship in translational research, Amsterdam, Netherlands; Most Outstanding Fellw Award, Clinical Fellow at Division of Hematology-Oncology, Vanderbilt University, Nashville, Tennessee; People's Choice Winner for Life Sciences/Health Care Track, Governor's Innovation Conference with technology; Teacher of the Year: Hematology-Oncology Fellows, Division of Hematology and Oncology, MedStar Georgetown University Hospital; Shining Star Award, Clinical Fellow at Division of Hematology-Oncology, Vanderbilt University, Nashville, Tennessee.